Yousef, Consuela Cheriece, Thomas, Abin ORCID: https://orcid.org/0000-0002-8283-6762, Matar, Manar Al, Ghandoura, Lama, Aldossary, Ibrahim, Almuhanna, Sarah Musa, Alhussain, Fatimah, Bishr, Fatmh Al, Aljohani, Raneem Mohammad, Balbaid, Aliya Najeeb, Nouh, Mahmoud, Almarashi, Abdulhalim and AlAmoudi, Reem 2021. Liraglutide effects on glycemic control and weight in patients with Type 2 Diabetes mellitus: a real-world, observational study and brief narrative review. Diabetes Research and Clinical Practice 177 , 108871. 10.1016/j.diabres.2021.108871 |
PDF
- Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) |
Abstract
Background Glycemic control and weight gain are two essential considerations in the pharmacological management of type 2 diabetes mellitus. Pharmacological agents are effective in lowering blood glucose levels but may result in significant weight gain. Liraglutide effectively maintains glycemic control while reducing weight. Methods This is a real-world study and brief narrative review of the effects of liraglutide on glycemic control and weight in adult patients with type 2 diabetes mellitus. The study uses data extracted from the electronic health record of the Ministry of National Guard-Health Affairs. Results In this study of 348 subjects, there was a statistically significant reduction in hemoglobin A1c of 0.9% (P < .0001) and weight of 2.3 kg (P < .0001). The majority (77.3%) were on concomitant insulin. Subjects with a baseline hemoglobin A1c greater than 9% had a significantly greater reduction than those below 9% (−0.7%; P < .0001). Those with a weight more than 100 kg had a significantly greater reduction than those below 100 kg (-0.9 kg; P = .0096). Conclusion In this real-world, observational study, liraglutide was shown to be effective in improving glycemic control and reducing weight in adult patients with type 2 diabetes mellitus.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine Centre for Trials Research (CNTRR) |
Publisher: | Elsevier |
ISSN: | 0168-8227 |
Date of First Compliant Deposit: | 18 January 2022 |
Date of Acceptance: | 24 May 2021 |
Last Modified: | 15 May 2023 11:29 |
URI: | https://orca.cardiff.ac.uk/id/eprint/146614 |
Actions (repository staff only)
Edit Item |